Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Autophagy Compound Library: Selection & Usage Guide

Autophagy Compound Library is a curated collection of bioactive small molecules designed to enable systematic interrogation of autophagy pathways for drug discovery and basic research applications.

Selleck Reference Number
L2600
Primary Application
Autophagy pathway screening and mechanistic studies
Recommended Format
Pre-dissolved or powder form in multi-well plate format for HTS compatibility
Target Classes Covered
mTOR, Beclin-1, PI3K, ULK1, AMPK, and other autophagy-related regulators

What Is the Autophagy Compound Library?

The Autophagy Compound Library (Lib412034) is a systematically assembled collection of small-molecule compounds specifically selected for their known or predicted activity on autophagy-related biological pathways. Autophagy is a highly conserved cellular degradation process by which cytoplasmic contents, including damaged organelles and misfolded proteins, are sequestered into autophagosomes and subsequently delivered to lysosomes for degradation and recycling. Dysregulation of autophagy has been implicated in a broad range of human diseases, including cancer, neurodegeneration, infectious disease, and metabolic disorders.

This library provides researchers with a ready-to-use pharmacological toolkit encompassing both autophagy inducers and inhibitors that act at multiple nodes of the autophagy cascade. Compounds in the library target key regulatory proteins and complexes such as mTORC1, the ULK1 initiation complex, the Beclin-1/VPS34 PI3K complex, ATG proteins involved in autophagosome elongation, and lysosomal function. The library is referenced under Selleck number L2600, reflecting its curation standard and cross-platform traceability.

Scientific Rationale and Target Coverage

The design of the Autophagy Compound Library is grounded in the well-established molecular framework of the autophagy pathway. Autophagy proceeds through several sequential stages: initiation, nucleation, elongation, maturation, fusion with the lysosome, and cargo degradation. Each stage is governed by distinct protein complexes and post-translational regulatory mechanisms, offering multiple pharmacological intervention points.

Key target classes represented in the library include:

  • mTOR pathway modulators: mTORC1 is the master negative regulator of autophagy initiation. Inhibitors of mTOR kinase or upstream activators such as PI3K/Akt potently induce autophagy by relieving suppression of the ULK1 complex.
  • AMPK activators: AMP-activated protein kinase (AMPK) acts as an energy sensor and positive regulator of autophagy, phosphorylating ULK1 to promote initiation under nutrient-deprived conditions.
  • Beclin-1/VPS34 complex regulators: This PI3-kinase complex is essential for phagophore nucleation. Compounds modulating Bcl-2/Beclin-1 interaction or VPS34 kinase activity directly control autophagosome formation.
  • Lysosomal function modulators: Chloroquine-class compounds and V-ATPase inhibitors block autophagic flux by preventing lysosomal acidification, serving as essential tools for flux assays.
  • ATG protein modulators: Compounds targeting ATG4, ATG7, and other ubiquitin-like conjugation system components affect autophagosome elongation and closure.

This multi-target coverage makes the library suitable for both pathway-wide phenotypic screens and focused mechanistic dissection of individual autophagy stages.

Storage, Handling, and Solubility Recommendations

Proper storage and handling of the Autophagy Compound Library are critical to maintaining compound integrity and biological activity throughout the experimental timeline. The following general guidelines apply; always consult the individual compound data sheets supplied with the library for compound-specific requirements.

Storage conditions: Library compounds should be stored at −20 °C in a dry, dark environment, unless otherwise specified on the accompanying compound data cards. Avoid repeated freeze-thaw cycles, which can degrade compound potency. Where the library is supplied in DMSO solution, ensure vials are tightly sealed to prevent moisture ingress and solvent evaporation.

Solubility and vehicle selection: The majority of compounds in autophagy-focused libraries are supplied as DMSO stock solutions, typically at 10 mM. When preparing working dilutions, the final DMSO concentration in cell-based assays should generally not exceed 0.1% (v/v) to avoid cytotoxic artifacts. For compounds with limited DMSO solubility, aqueous co-solvent systems or mild sonication may be required. Refer to individual solubility data provided with each compound.

Handling precautions: Handle all compounds under standard laboratory safety conditions, wearing appropriate personal protective equipment. Many small-molecule kinase inhibitors and lysosomal modulators in this class of library may have cytotoxic or genotoxic potential at high concentrations. Consult the Safety Data Sheet (SDS) for each compound prior to use.

Reconstitution: If compounds are supplied in powder form, reconstitute in the recommended solvent as indicated in the compound data sheet. Allow the solution to equilibrate to room temperature before opening vials to avoid condensation-related solubility issues.

Experimental Applications and Assay Design

The Autophagy Compound Library supports a wide range of experimental paradigms in autophagy research. Below are key application areas and practical considerations for assay design.

High-throughput phenotypic screening: The library is well-suited for 96-well or 384-well format screens using fluorescence-based autophagy reporters such as GFP-LC3 puncta quantification, tandem mCherry-GFP-LC3 flux assays, or lysosomal dye accumulation (e.g., LysoTracker). Automated imaging platforms enable quantitative, unbiased analysis of autophagosome formation and autophagic flux across the entire compound set.

Target-focused mechanistic studies: Researchers investigating a specific node of the autophagy pathway can use subset panels from the library to perform dose-response experiments, combination studies, or time-course analyses. Western blotting for LC3-I/II conversion, p62/SQSTM1 degradation, and Beclin-1 or phospho-ULK1 levels serves as a standard biochemical readout complementing imaging assays.

Disease-relevant cellular models: The library has broad applicability across disease-relevant model systems, including cancer cell lines (to study autophagy as a survival or death mechanism), neuronal cultures (to model neurodegenerative proteinopathies), and infection models (to examine xenophagy). Appropriate positive and negative controls—such as rapamycin (mTOR inhibitor) for induction and bafilomycin A1 (V-ATPase inhibitor) for flux blockade—should be included in every experiment.

Combination and synergy studies: Because the library covers multiple pathway nodes, it enables matrix screening approaches to identify synergistic compound combinations that may enhance therapeutic efficacy or overcome resistance mechanisms in cancer biology.

Quality controls: Include vehicle-only controls (DMSO at matched concentrations) and reference compounds at defined concentrations in every plate to monitor assay performance, Z-factor, and signal window across screening runs.

Ordering, Customization, and Technical Support

The Autophagy Compound Library (Lib412034) is available for order through Aladdin Scientific. When placing an order, researchers should specify the preferred format (DMSO solution or powder), plate format (96-well or 384-well), and concentration requirements to ensure the library arrives ready for immediate integration into existing screening workflows.

Customization options: Depending on project needs, subset libraries or cherry-picked compound sets from the full autophagy collection may be available. Contact Aladdin Scientific technical support to discuss custom library configurations, compound replacement options for depleted wells, and volume requirements for large-scale screening campaigns.

Documentation provided: Each library shipment is accompanied by a compound manifest listing compound names, catalog numbers, molecular weights, purities, and solubility data. Certificate of Analysis (CoA) documents are available upon request and confirm compound identity and purity as determined by HPLC and MS characterization.

Technical support: Aladdin Scientific provides technical consultation for assay design, compound selection rationale, and troubleshooting of common autophagy screening challenges. Researchers are encouraged to contact the technical team prior to initiating large-scale screens to optimize experimental parameters and maximize data quality.

Frequently asked questions

What types of compounds are included in the Autophagy Compound Library?

The Autophagy Compound Library (Lib412034) contains a curated set of small molecules that modulate autophagy at multiple pathway nodes, including mTOR inhibitors, AMPK activators, PI3K/Beclin-1 complex regulators, lysosomal function modulators, and ATG protein inhibitors. The collection encompasses both autophagy inducers and inhibitors to support diverse experimental needs.

How should I measure autophagic flux when screening with this library?

The most reliable approach to measuring autophagic flux is to use a tandem fluorescent LC3 reporter (mCherry-GFP-LC3), which distinguishes autophagosomes (GFP+ mCherry+) from autolysosomes (GFP− mCherry+) based on pH sensitivity. Complementary biochemical readouts include LC3-II accumulation in the presence and absence of a lysosomal inhibitor (e.g., bafilomycin A1) and p62/SQSTM1 turnover. Including such flux controls is essential when screening the Autophagy Compound Library to correctly interpret whether a compound induces or blocks autophagy.

What DMSO concentration is safe for autophagy cell-based assays?

For most cell-based autophagy assays, the final DMSO concentration should be kept at or below 0.1% (v/v) to minimize cytotoxic and autophagy-modulating artifacts. At higher concentrations, DMSO itself can perturb membrane integrity and stress-response pathways including autophagy, confounding results. Always run a DMSO vehicle control at the same concentration used for compound treatment in every experiment.

Can the Autophagy Compound Library be used in vivo or in primary cell models?

While the Autophagy Compound Library is primarily designed and validated for in vitro cell-based screening, many of the included compounds have reported in vivo activity in the published literature. Use in primary cells or in vivo models requires additional optimization of dosing, formulation, and pharmacokinetic considerations. Researchers should consult individual compound data sheets and published literature for in vivo applicability, and contact Aladdin Scientific technical support for guidance on translational applications.

References

  1. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annual Review of Cell and Developmental Biology. 2011;27:107-132. doi:10.1146/annurev-cellbio-092910-154005
  2. Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1-2):11-42. doi:10.1016/j.cell.2018.09.048
  3. Klionsky DJ et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17(1):1-382. doi:10.1080/15548627.2020.1797280
  4. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nature Reviews Drug Discovery. 2012;11(9):709-730. doi:10.1038/nrd3802

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Autophagy Compound Library: Selection & Usage Guide" Aladdin Knowledge Base, updated 19/11/2026. https://www.aladdinsci.com/eu_pt/faqs/autophagy-compound-library-selection-usage-guide-en.html
Was this article helpful? Yes No 7 out of 14 found this helpful

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.